Categories: >>

Patents

Updates

• Science, Intellectual Property, and Legislation in the 110th Congress
• British Scientists "Invent Around" Protections on Patented Drug
• Eli Lilly Patent Decision Upheld
• Google Launches Beta Version of Patent Search Tool
• "Philadelphia Consensus Statement" Calls upon WHO, Academia, to Bolster Poor Nations' Benefits from Health Research
• WIPO Announces Third Session for Provisional Committee on Development Agenda
• EU Proposal for Patent Reform Proceeds with Significant Changes
• WTO Director-General Calls Upon Poor Nations to Enact Compulsory Licensing for Critical Patented Drugs
• USPTO to Re-examine Basis for Three Patents on Human Embryonic Stem Cells
• Public Patent Foundation Formally Requests Review and Revocation of Four Patents on Genetically Engineered Crops
• Changes to European Patent Policy Forthcoming?
• New India-based Initiative to Oppose Patenting of HIV Medications
• Patent Interference Appeals Against Biopharmaceutical Company Dropped
• Generic Copy of Anti-clotting Drug Forced Off of Market in U.S.
• Public Comment Period on USPTO Draft Strategic Plan Now Open
• USPTO Electronic Patent Information Interface Requires Transition for Users
• Patent Reform Legislation Underway in the Senate
• Generic Drug-maker Challenges Patent
• Canada Institutes Humanitarian Endeavor to Make Information and Medicine More Easily Available to Impoverished Countries
• Federal Trade Commission Weighs in on Access to Generic Drugs
• EU Patent Policy: The Costs of Greater Efficiency?
• WIPO Development Agenda Discussions Temporarily Stalled
• Korea Reforms Health Insurance Policy, Tightens Funding for Multinational Drug Companies
• Late Patent Extension Request Spurs Proposed Legislation in House
• US-Morocco FTA Provisions for Intellectual Property Rules Draw Attention from the United Nations
• Proposed Amendment to WTO Could Nullify Existing Patents
• FDA Approves a "Biosimilar" Copy of a Biotechnology-Derived Drug
• WHO to Study Effects of International Drug Patent System on Low-Income Nations
• USPTO: Notice of Collection of Practitioners’ E-mail Addresses
• USPTO Grants Second Reexamination Request in Two Months to Electronic Frontier Foundation
• Search the USPTO's New Online Tool for Patent Appeals Decisions
• Gilead Sciences' Plan for Non-exclusive Licensing of AIDS Drug Met with Mixed Reactions
• Patent Dispute Arises From Discovery Made Over 20 Years Ago
• FTC Reports on Legal Settlements to Generic Drug Manufacturers
• April 26: Sixth World Intellectual Property Day Observed With Activities Throughout the World
• New Trade Association Analysis: Generic Forms of Widely-used Drugs Face Challenges in the Marketplace
• WIPO Initiative to Harmonize Patent Systems Delayed Until September
• Heavy Volume of Patent Applications Before FDA's Office of Generic Drugs Could Bolster Profits of Name-brand Drug Producers
• UK Patent Office Establishes Mediation Service
• Patenting of AIDS Drug in India Meets Legal Resistance
• Sanofi-Aventis and Bristol-Myers Squibb Reach Settlement on Patent for Well-Known Blood Thinner
• Tuesday, March 21: Landmark Patent Case Before Supreme Court
• EU Patent Debate Begins With Vote Against "Mutual Patent Recognition"
• Patent Status as a Factor in Drug Pricing?
• RIM and RTP Settle Dispute Over BlackBerry Patent Dispute
• WIPO Open Forum on the Draft Substantive Patent Law Treaty in Progress
• Cleveland Clinic Grants Exclusive Rights to Company to Advance Therapy for Damaged Hearts
• Review of USPTO’s February 16 Open Source Software Community Meeting
• Second USPTO Town Hall Meeting on Proposed Changes to Existing Patent Rules
• USPTO Post-Press Release on Town Hall Meeting for Proposed Changes to Patent Rules
• U.S. Copyright Office Releases Report on "Orphan Works"
• New Findings Suggest Prevalence of Small Errors in Most U.S. Patents
• Legal Dispute Ensues Between Researcher and Biotechnology Firm
• European Commission to Solicit Comments on Future Patent Policy
• U.S.-Thai Trade Talks Muddled Over Intellectual Property Rights Provisions
• Traditional Knowledge Digital Library Seeks to Prevent Biopiracy
• USPTO Proposes New Rules to Streamline Patenting Process
• Agreement with Korean Intellectual Property Office to Lessen Burden on USPTO
• Approval Process for Biotech-derived Generic Drugs Not Yet Established
• Indian Drug Maker Pursues Legal Strategy to Market Generic Pharmaceuticals
• U.S. Critical of Israel's Patent Extension Policy
• Amendment to WTO's Intellectual Property Rules Eases Poor Countries' Access to Generic Drugs
• 2005: Record Number of Patent and Trademark Applications Received by USPTO
• Intellectual Property Protection Stalls U.S.-Andean Nation Trade Talks
• WTO Grants Poorest Nations Less Time than Requested to Adhere to International Intellectual Property Rules
• Visit the Patent Commons Project Online
• China Second only to U.S. in Ownership of Health-Based Nanotechnology Patents
• BioShield II Legislation Closer to Compromise on Drug Patenting
• India Objects to U.S. “Contract-based Approach” in World Trade Organization Negotiations
• Representative Brown Introduces Bill to Enact Compulsory Licensing During Healthcare Crises
• Senator Schumer Calls for “Immediate Licensing” to Allow U.S. Manufacturers to Produce the Antiviral Drug Tamiflu
• BBC Develops Open Source Internet Video Platform
• European Commission Remains Vague on Biotechnology Patenting; Industry Disappointed
• South Centre and CIEL: Quarterly Update on IP and Development
• White House Creates New IP Enforcement Position
• Emory Sells AIDS Drug Rights for Record $525 Million
• Patent Reform Report Released by Congressional Research Service
• Brazil and Abbott Reach Deal on Kaletra
• Europe Rejects Software Patent Directive
• Patent Reform Bills Move to Full House Judiciary Committee
• Presidential Advisors Comment on Nanotechnology IP
• Brazil May Break Patent on HIV/AIDS Drug
• ETC Reports on Impact of Nanotechnology Patents for Global South
• Supreme Court Interprets Broader Exemption for Drug Research
• The Patent Act of 2005 Introduced in House
• Patent Reform Bill Expected in House This Week
• WHO Holds Workshop and Open Forum on IP, Innovation and Health
• Brazil’s Lower House Votes to Suspend AIDS Drug Patents
• UK Workshops Examine Definition of Patentable Software
• University of Pennsylvania Strategizes to Boost Tech Transfer Revenue
• WHO Studies on IP and Health Available Online
• Debate on Bioshield II Patent Provisions at Center for American Progress
• Patent Trolls in the News
• New Patent Bill Is Expected In Congress
• IBM Will Share More Patented Inventions in New Strategy
• Japan Establishes High Court for IP Disputes
• House and Senate Hearings Will Address Patent Reform
• Federal Circuit Court to Decide If Expressed Sequence Tags Are Patentable
• Merck v. Integra Briefs Available Online
• Senators Propose Patent Extensions to Spur Biodefense R&D
• Through Website, Scientists Can Tackle Companies' R&D Challenges
• Study Finds Many Human Gene Patent Claims Fall Short of Legal Standard
• European Policy for Intellectual Property Conference: Papers Available
• Graham Dutfield Editorial: "The US and Europe Are Intellectual Property Fundamentalists"
• EPO Upholds Revocation of Neem Patent
• EU Ministers Support Software Patent Law
• Amicus Brief on Research Exemption Submitted to Supreme Court
• Proposed Medical R&D Treaty Would Provide Alternative Incentives for Innovation
• University Inventions Being Licensed Closer to Commercialization
• Model IP Agreements Aim to Encourage University-Industry Collaboration in Britain
• Court Rules Against Nobel Laureate in Yale Patent Dispute
• OECD Issues Draft Guidelines for Licensing Genetic Inventions
• USPTO Rejects Patent on Human-like Organism
• New Plant Biotechnology Will Be Open-Source
• USPTO Would Keep Fees in FY 2006, According to President’s Budget Request
• Brazil Reshapes Debate on Intellectual Property
• USPTO Names First University Rep. to Patent Public Advisory Committee
• Open Source Biology Evolves
• Sandia Publicizes IP Available for Licensing
• China Must Criminalize IP Violations, Says US Commerce Secretary
• Supreme Court Will Hear Merck v. Integra
• Counterfeiting and Piracy in China - New York Times Magazine
• Digital Library to Protect Indigenous Knowledge
• Nanotechnology Patents Inject Uncertainty into Emerging Industry
• USPTO Proposes New Rules to Streamline Patent Review Process
• April 2005: WIPO Meeting on Establishing a Development Agenda
• Germany Passes New Biotech Patent Law
• NY Times Op-Ed: More Academics Should Patent
• NIH Requests Comments on Best Practices for Licensing Genomic Inventions
• Profits from Indigenous Knowledge Must Be Shared: Opinion – The Times of India
• WHO Initiates 23 Studies on IPRs, Innovation and Public Health
• GSK Tells Blair to Press G8 for Patent Reform
• IP Owners Oppose USPTO Fee Increase, Unless Profits Remain in Agency
• University of New Mexico Wins IP Dispute
• EU Announces Strategy to Halt Piracy and Counterfeiting Abroad
• Patent Challenge Against Columbia University Dismissed
• Creative Commons Hires Science Director
• Epogen Patent Ruling: UK Will Not Allow Overly Broad Claims
• UNEP and WIPO Release Study on Access and Benefit-Sharing
• European Commission Proposes Generic Export Regulation
• Malaysia Considers Bayh-Dole Equivalent
• Mexican Universities Could Gain Right to Profit From Inventions
• NAS Committee on IPRs in Genetic and Protein-Related Inventions: Meeting Transcript and Presentations Available
• “Innovation Sails Free”: Newsweek Article on Open Source Science
• Food Scientist Wins Infringement Suit Against ConAgra
• Greenpeace Challenges Stem Cell Patent
• UK Court Revokes Amgen Patent
• Venture Capitalists Support CA Stem Cell Initiative
• Judge Rules for Amgen Patents
• Digene Settles Patent Dispute over HPV Test
• Patents in Pharmaceutical R&D: Discussion in Bulletin of the WHO
• Open Source Biotech Starts in Earnest
• Funding Pharmaceutical R&D: Alternatives to the Patent System
• Book Faults Patent Reforms for Slowing Innovation
• GSK Licenses AIDS Drugs in Kenya
• The Scientist: From the Bench to the Bar
• Zambia Issues Compulsory License for AIDS Drug
• Expiring Patents Drive Drug Companies to Merge
• WIPO Members Will Meet Next Week
• Pubpat Challenges Pfizer's Lipitor Patent
• WIPO “Development Agenda” Demanded by Brazil and Argentina
• China Considering Compulsory Licenses for AIDS Drugs
• Chiron Settles HIV Test Patent Dispute With Roche
• South African Government Says Country "Needs to File More Patents"
• ALRC Recommends Gene Patenting Changes for Australia
• AIDS Drugs: Is Patent the Obstacle?
• Congressman Brown Asks Thompson to Reverse NIH Norvir Decision
• USPTO Deals Second Blow to Eolas Browser Patents
• Acacia Demands License Fees for Internet Streaming Media
• FDA Warns of Terrorist Drug Tampering
• IBM Pledges No Patent Attacks Against Linux
• NIH Decides Not to Intervene on Norvir Pricing
• Hewlett-Packard Rolls Out Linux Laptop
• I.B.M. Will Reveal Source Code Worth $85 Million
• Merck Licenses AIDS Drug to South African Generic Manufacturer
• Linux Might Infringe 283 Patents
• Poor Countries Can Import Generics Without E.U. Rule
• Chinese Challenge Diabetes Drug Patent
• Microsoft Will File 50 Percent More Patents
• AIDS Healthcare Foundation Drops Norvir Lawsuits
• Language Barrier Slows Access to Generic Drugs
• Text of U.S. Representatives' Letter on FTAs
• US-Morocco FTA: Strongest IP Protection Yet
• AHF and Abbott settle
• Congress Approves Project BioShield
• China Overturns Viagra Patent
• EFF: The patent hit list is out
• European Patent Office Upholds Harvard Mouse Patent
• Generic 3-in-1 AIDS Pill Effective in Study
• Senate Passes Three Bills that Affect Intellectual Property
• Mylan Sues FDA Over Generic Pain-Relief Patch
• Chiron Relaxes License Policy for Hepatitis C Genome
• African Agricultural Technology Foundation Opens in Kenya
• Draft text of US-Bahrain Free Trade Agreement
• Singapore Boosts Intellectual Property Protection
• Open-Source Drug Discovery Proposed for Neglected Diseases
• Aetna Drops Antitrust Suit Against Abbott
• Central American Free Trade Agreement (CAFTA) and U.S.-Bahrain FTA
• Both Sides Speak Out at Norvir March-In Meeting
• Canadian Supreme Court rules in Favor of Monsanto
• Speakers for NIH May 25 Norvir March-in meeting
• PTO Proposes to Allow Generics to Challenge Patents at Issuance
• Sens Hollings, McCain, and Schumer ask FTC to inquire into Norvir price increase
• Breast Cancer Gene Patent Revoked in Europe
• Developing countries at odds with Trilateral Offices
• Patent Office Grants PUBPAT Request To Reexamine Cotransformation Patent
• Six House Republicans Ask for Hearings on Norvir Pricing
• HHS Sec. Declares Drug Importation "Helpful, Inevitable"
• The National Academies' National Research Council Asks Congress for Research Protection Legislation
• New Case Against Abbott Laboratories
• Federal hearing on importing cheaper drugs
• Appeals Ruling Could Impact Combination Drug Development
• WTO to host public symposium on the Doha Agenda
• Patent threat to anti-HIV compounds is lifted
• USPTO Supports Greater Protection for Traditional Knowledge and Folklore
• CREATE Act of 2004 Passed by House
• WHO launches intellectual property commission
• Pro bono lawyers challenge patents on Maca
• Supreme Court decides not to review Duke University v. John Madey
• Peruvian delegation to WIPO submits report on Maca patents

Legislation

• PACE Through Education and Research Act
• The Patent Reform Act of 2005
• Pharmaceutical Market Access and Drug Safety Act of 2004
• Cooperative Research and Technology Enhancement (CREATE) Act of 2004
• US Trademark and Patent Fee Modernization Act of 2003
• Greater Access to Affordable Pharmaceuticals Act
• Greater Access to Affordable Pharmaceuticals Act (S 1225)
• Patent and Trademark Office Authorization Act of 2002

Hearings

Publications

• A Fair Deal for the Future: Flexibilities Under TRIPS
• A Patent System for the 21st Century
• American Patent Policy, Biotechnology, and African Agriculture: The Case for Policy Change
• Facilitating humanitarian access to pharmaceutical and agricultural innovation
• Final Report of the Sixth Session of the WIPO IGC on Intellectual Property and Genetic Resources, Traditional Knowledge and Folklore
• Financing Drug Research: What are the Issues?
• Genes and Ingenuity: Gene Patenting and Human Health
• Has the Implementation of the TRIPS Agreement in Latin America and the Caribbean Produced Intellectual Property Legislation that Favours Public Health?
• Integrating Intellectual Property Rights and Development
• Ownership of knowledge - the role of patents in pharmaceutical R&D
• The Effects of Patenting in the AAAS Scientific Community
• Traditional Knowledge and Intellectual Property

Meetings

• 15 Feb 2007 14:00: Oversight Hearing on American Innovation at Risk: “The Case for Patent Reform”
• 17 Jan 2007 10:00: Hearing: Paying off Generics to Prevent Competition with Brand Name Drugs
• 16 Jan 2007 8:30: Symposium: Effects of Intellectual Property Protections on Scientific Research
• 8 Sep 2006: 11th Annual Independent Inventors Conference
• 12 Jul 2006: USPTO Conference on Protecting Your Intellectual Property
• 26 Jun 2006 9:00: Secretary's Advisory Committee on Genetics, Health, and Society: 10th Meeting
• 23 May 2006 14:00: Perspectives on Patents: Post-Grant Review Procedures and Other Litigation Reforms
• 6 May 2006 9:00: USPTO Meeting on Peer to Patent Project
• 27 Apr 2006 9:00: Oversight Hearing on Patent Harmonization
• 25 Apr 2006 9:00: Semiconductor Customer Partnership meeting
• 10 Apr 2006 8:00: USPTO Design Day
• 26 Mar 2006 16:30: Washington Academy of Sciences-CapSci 2006 SIPPI Symposium
• 28 Feb 2006 13:00: Second USPTO Town Hall Meeting on Proposed Changes to Existing Patent Rules
• 17 Feb 2006 14:00: AAAS-SIPPI Annual Meeting: Briefing on Effects of Intellectual Property on Academic Research
• 1 Feb 2006 14:00: Town Hall Meeting on USPTO Proposed Changes to Patent Rules
• 12 Dec 2005 9:00: Meeting of the International Authorities Under the Patent Cooperation Treaty
• 27 Nov 2005 9:30: Expert Group on Technology Transfer and Scientific and Technical Cooperation
• 17 Nov 2005 14:00: Report Release and Public Briefing: IP Rights in Genomic and Proteomic Research
• 27 May 2005 8:30: Gene Patents and Public Health
• 11 Mar 2005 8:30: Biotechnology & Intellectual Property: Current Controversies
• 19 Feb 2005 13:00: AAAS Annual Meeting - Science & Intellectual Property Briefing
• 18 Feb 2005: Town Meeting on Patent System Reform
• 10 Jan 2005 8:00: Advancing Knowledge and the Knowledge Economy
• 20 Oct 2004 12:00: Gene Patenting and Human Health - Lunchtime Talk
• 4 Oct 2004: BIO IP Counsel Committee Meeting
• 18 Sep 2004: Patent Policy: Using, Abusing and Reforming
• 13 Sep 2004: The Future of WIPO
• 8 Sep 2004 12:45: "Patents and Biotechnology: A U.S. Patent System for the 21st Century" Lunch talk
• 5 Aug 2004 8:00: National Academies: IP in Genomic and Protein Research and Innovation
• 25 May 2004 9:00: NIH Norvir March-in Meeting
• 25 May 2004: Multilateralism at a Crossroads: WTO annual public symposium
• 17 May 2004: WIPO Comes to Silicon Valley
• 10 May 2004: Standing Committee on the Law of Patents (SCP) (Tenth session)
• 5 May 2004 10:00: Fifth listening session on drug importation
• 3 May 2004: Working Group on Reform of the PCT (Sixth session)
• 22 Apr 2004: 29th Annual Forum on Science and Technology Policy
• 19 Apr 2004 10:30: NAS to Release Report: A Patent System for the 21st Century
• 15 Mar 2004: Intergovernmental Committee on Intellectual Property and Genetic Resources, Traditional Knowledge and Folklore (Sixth Session) WIPO

Subcategories

• Patent Reform
• Research Exemption
• Technology Transfer